Literature DB >> 18231705

Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study.

M Nakamura1, I Miyazawa, K Fujihara, I Nakashima, T Misu, S Watanabe, T Takahashi, Y Itoyama.   

Abstract

OBJECTIVE: To delineate the MRI features that distinguish neuromyelitis optica (NMO) from multiple sclerosis (MS).
METHODS: We compared the distribution of the spinal cord lesions by analyzing 1) lesion area, 2) lesion density (by superimposing the lesions onto the standard sections of the cervical and thoracic cord with appropriate transparencies using computer software), and 3) T1-hypointensity in axial sections of MRI in NMO and MS.
RESULTS: In NMO, 60-70% of the cervical and thoracic cord MRI lesions occupied more than half of the cord area and mainly involved the central gray matter in the acute stage. In the chronic stage, half or more of the lesions were localized at the central gray matter region. The lesion superimposition analysis also revealed much higher densities in the central gray matter region than in the peripheral white matter regions. Two patients with NMO had T1-hypointense lesions in the central region. In contrast, over 80% of the lesions in MS were localized in the lateral and posterior white matter regions of the cord in the chronic as well as acute stage. Lesion densities were much higher in the lateral and posterior white matter regions than in the central gray matter region. None of the lesions in MS were T1-hypointense.
CONCLUSIONS: These MRI findings strongly suggest a preferential involvement in the spinal central gray matter in NMO which is distinct from MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18231705     DOI: 10.1007/s00415-008-0545-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange.

Authors:  Shohei Watanabe; Ichiro Nakashima; Isabelle Miyazawa; Tatsuro Misu; Yusei Shiga; Yoichi Nakagawa; Kazuo Fujihara; Yasuto Itoyama
Journal:  J Neurol       Date:  2007-03-14       Impact factor: 4.849

2.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Authors:  Sean J Pittock; Brian G Weinshenker; Claudia F Lucchinetti; Dean M Wingerchuk; John R Corboy; Vanda A Lennon
Journal:  Arch Neurol       Date:  2006-07

3.  Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica.

Authors:  T Misu; K Fujihara; I Nakashima; S Sato; Y Itoyama
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

4.  Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.

Authors:  Tatsuro Misu; Kazuo Fujihara; Masashi Nakamura; Kazuhiro Murakami; Minoru Endo; Hidehiko Konno; Yasuto Itoyama
Journal:  Tohoku J Exp Med       Date:  2006-07       Impact factor: 1.848

5.  Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis.

Authors:  I Nakashima; K Fujihara; N Okita; S Takase; Y Itoyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

6.  Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

Authors:  J C Vernant; P Cabre; D Smadja; H Merle; I Caubarrère; J Mikol; C M Poser
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

7.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

8.  Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Authors:  R N Mandler; L E Davis; D R Jeffery; M Kornfeld
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

9.  T1 hypointensity of the spinal cord in multiple sclerosis.

Authors:  N A Losseff; L Wang; D H Miller; A J Thompson
Journal:  J Neurol       Date:  2001-06       Impact factor: 4.849

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  27 in total

1.  [Pain in multiple sclerosis and neuromyelitis optica spectrum disorders].

Authors:  Hannah L Pellkofer; Tania Kümpfel
Journal:  Schmerz       Date:  2021-05-25       Impact factor: 1.107

Review 2.  Neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

3.  A case of simultaneous neuromyelitis optica spectrum disorder and subacute combined degeneration.

Authors:  Nobuyuki Ishii; Hitoshi Mochizuki; Toshiyuki Takahashi; Kazutaka Shiomi; Masamitsu Nakazato
Journal:  Neurol Sci       Date:  2013-03-02       Impact factor: 3.307

Review 4.  Segmentation of the human spinal cord.

Authors:  Benjamin De Leener; Manuel Taso; Julien Cohen-Adad; Virginie Callot
Journal:  MAGMA       Date:  2016-01-02       Impact factor: 2.310

Review 5.  Magnetic resonance imaging in immune-mediated myelopathies.

Authors:  M J Wendebourg; S Nagy; T Derfuss; K Parmar; R Schlaeger
Journal:  J Neurol       Date:  2019-01-29       Impact factor: 4.849

6.  Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.

Authors:  Raffaele Iorio; Valentina Damato; Massimiliano Mirabella; Amelia Evoli; Alessandro Marti; Domenico Plantone; Giovanni Frisullo; Anna Paola Batocchi
Journal:  J Neurol       Date:  2013-06-21       Impact factor: 4.849

7.  Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?

Authors:  Jonathan James Downer; Maria Isabel Leite; Ranjana Carter; Jacqueline Palace; Wilhelm Küker; Gerardine Quaghebeur
Journal:  Neuroradiology       Date:  2011-05-07       Impact factor: 2.804

8.  Association of neuromyelitis optica with severe and intractable pain.

Authors:  Peiqing Qian; Samantha Lancia; Enrique Alvarez; Eric C Klawiter; Anne H Cross; Robert T Naismith
Journal:  Arch Neurol       Date:  2012-11

Review 9.  Conventional and advanced imaging in neuromyelitis optica.

Authors:  Y Barnett; I J Sutton; M Ghadiri; L Masters; R Zivadinov; M H Barnett
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

Review 10.  The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Yong Guo; Bogdan F Gh Popescu; Kazuo Fujihara; Yasuto Itoyama; Tatsuro Misu
Journal:  Brain Pathol       Date:  2014-01       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.